Press Releases

Year

23 Aug '24

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

PDF Version

FRANKLIN, TN , Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on August 21, 2024 (the

11 Jul '24

IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors

PDF Version

Golden, CO , July 11, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ: BACK) (the “Company” or “IMAC”), a leading innovator in proteomics research and technology, announced the appointment of Dr. Peter Beitsch and Dr. Matthew Schwartz to its Board of Directors, effective June 26, 2024 .

24 May '24

IMAC Holdings Announces Leadership Succession

PDF Version

Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn. , May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings , Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the board of directors and executive team. Faith Zaslavsky has been appointed chief executive officer,

07 May '24

IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business

PDF Version

FRANKLIN, Tenn. , May 07, 2024 (GLOBE NEWSWIRE) -- On May 1, 2024 , as previously announced, pursuant to that certain Settlement and Release Agreement, by and between IMAC Holdings, Inc. (NASDAQ: BACK) (“BACK”) and Theralink Technologies, Inc. (“Theralink”), BACK acquired the assets of Theralink,